📑Soutien filiere radio-pharmaceutique
Procurement process summary
This process is to purchase Soutien filiere radio-pharmaceutique.
This contract was awarded by 🇫🇷 Groupement d'intérêt public Arronax for an amount of EUR 146,520 to 1 supplier. It was published on 2018-08-21 through open
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
Buying entity🇫🇷 Groupement d'intérêt public Arronax Buying unitnot reported Publication date2018-08-21 Contest statusnot reported DescriptionAchat d'une prestation d'assistance et de conseil sur le developpement d'une filiere radiopharmaceutique implantee en Pays de la Loire.Awards
This award was granted to Read pharma by Groupement d'intérêt public Arronax for an amount of EUR 146,520. The procurement process was conducted through open for the category of services. The award was granted on 2018-10-09. This is award number 1.
| Supplier | Amount | Award date | Award number |
|---|---|---|---|
| 🇫🇷 Read pharma | EUR 146,520 | 2018-10-09 | 1 |
Market context and opportunities
The execution of this contract allows the entity Groupement d'intérêt public Arronax to fulfill its public service objectives efficiently.
The open purchase modality ensures that the process is transparent and compliant with regulations.
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
This transparency in public procurement promotes fair competition, prevents corruption, and ensures that public resources are used efficiently for the benefit of citizens.
Additional data
Contract NumberFR_ocds-70d2nz-1a2cfdcd-2eb4-4912-b4e0-246d171f598a-award-1Publication date2018-08-21Contract datenot reportedAward date2018-10-09CategoriesservicesPurchase modalityopenMethod detailspt_openStatusnot reportedData sources
Sociedad.info publishes data from official sources, in compliance with public information access laws. Public access to this data is a civic right that helps hold government accountable. This data, including names and identifiers, is already public in the official source. Read our privacy policy.
